M&A related:
- CAB -7.1% (Cabela's & Bass Pro receive request for second request from the Federal Trade Commission relating to their pending merger)
Other news:
- INNL -49.7% (received FDA Refusal to File letter for XARACOLL - its product candidate for postsurgical pain treatment; downgraded to Neutral from Buy at Janney; downgraded to Mkt Perform at FBR & Co; downgraded to Mkt Perform from Mkt Outperform at JMP Securities),
- GEVO -8.5% (announces 1-for-20 reverse stock split),
- DKS -0.2% (light volume - CAB sympathy)